In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The update includes Pfizer Inc.’s (NYSE:PFE) Abrysvo (Respiratory Syncyt The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu ...

The technology behind Moderna’s COVID-19 vaccine — mRNA packaged in lipid nanoparticles — has the potential to reduce disparities in global health and help fight future pandemics.

Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that its manufacturing facility in the UK has been granted a manufacturer’s license by the Medicines and Healthcare products Regulatory Agency ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

We recently published a list of 10 Stocks with Potential to Explode in 2025. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks with ...

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global ...